tofisopam has been researched along with Psychotic Disorders in 1 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tofisopam is a member of the 2,3-benzodiazepine compound family which is marketed for the treatment of anxiety in some European countries." | 1.36 | The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. ( Rundfeldt, C; Socała, K; Wlaź, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rundfeldt, C | 1 |
| Socała, K | 1 |
| Wlaź, P | 1 |
1 other study available for tofisopam and Psychotic Disorders
| Article | Year |
|---|---|
The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis.
Topics: Animals; Antidepressive Agents; Benzodiazepines; Disease Models, Animal; Isoenzymes; Male; Mice; Pho | 2010 |